ADAR and systemic sclerosis: Our data demonstrated that IL-1β is also critically important for ADAR1-mediated SSc development, as supplementation of IL-1β significantly reverses the reduction of skin fibrosis observed in ADAR1mφ-/- mice treated with bleomycin.